Jds Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for JDS PHARMS, and what generic and branded alternatives to JDS PHARMS drugs are available?
JDS PHARMS has two approved drugs.
Drugs and US Patents for Jds Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jds Pharms | ESKALITH | lithium carbonate | TABLET;ORAL | 017971-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Jds Pharms | ESKALITH CR | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 018152-001 | Mar 29, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.